How Biotech Can Succeed Outside the Hubs
Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.
‘Very concerning’: What NIH cuts would mean for D.C.-area biotech companies, universities
The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.
Level Zero Health banks $6.9M to prove wearable medtech can take the strain out of hormone testing
Level Zero Health, a female-founded medical device startup that's aiming to break new ground by developing a device for ...
Le Lézard18h
Michel Lussier Joins Caristo Diagnostics Board of Directors
Caristo Diagnostics, a global leader in cardiovascular disease diagnostics and risk prediction, announced that Michel Lussier has joined the company's board of directors, effective ...
12 Chicago startups to watch in 2025
Previous Startups to Watch selections include Synpaticure, a virtual-care platform that closed on $25 million in new funding ...